Transcatheter aortic valve implantation in high-risk patients with severe aortic stenosis

Circulation Journal

Volumn 74, Issue 8, 2010, Pages 1513-1517

  Hara, Hidehiko ^a   Schwartz, Robert S ^b  

^a TOHO UNIVERSITY OHASHI MEDICAL CENTER   (Japan)

^b MINNEAPOLIS HEART INSTITUTE FOUNDATION   (United States)

Author keywords

Aortic stenosis; Elderly; Percutaneous aortic valve replacement; Transcatheter aortic valve implantation

Indexed keywords

CHROMIUM; COBALT; NITINOL; POLYURETHAN; STAINLESS STEEL;

AORTA STENOSIS; AORTA VALVE PROSTHESIS; AORTA VALVE REPLACEMENT; ARTIFICIAL HEART PACEMAKER; CLINICAL TRIAL; DISEASE SEVERITY; ELDERLY CARE; EQUIPMENT DESIGN; HEART BUNDLE BRANCH BLOCK; HEART INFARCTION; HIGH RISK PATIENT; HUMAN; JAPAN; MEDICAL EXPERT; NONHUMAN; PATIENT SAFETY; REVIEW; STROKE; SURGICAL APPROACH; SURGICAL TECHNIQUE; TREATMENT OUTCOME;

AGED; AORTIC VALVE; AORTIC VALVE STENOSIS; HEART CATHETERIZATION; HEART VALVE PROSTHESIS IMPLANTATION; HUMANS; JAPAN;

EID: 77955084165     PISSN: 13469843     EISSN: 13474820     Source Type: Journal    
DOI: 10.1253/circj.CJ-10-0557     Document Type: Review

References (15)

1. Hara H, Pedersen WR, Ladich E, Mooney M, Virmani R, Nakamura M, et al. Percutaneous balloon aortic valvuloplasty revisited: Time for a renaissance? Circulation 2007; 115: e334-e338.
2. Cribier A, Eltchaninoff H, Bash A, Borenstein N, Tron C, Bauer F, et al. Percutaneous transcatheter implantation of an aortic valve prosthesis for calcifc aortic stenosis: First human case description. Circulation 2002; 106: 3006-3008.
3. Iung B, Baron G, Butchart EG, Delahaye F, Gohlke-Bärwolf C, Levang OW, et al. A prospective survey of patients with valvular heart disease in Europe: The Euro Heart Survey on Valvular Heart Disease 1. Eur Heart J 2003; 24: 1231-1243.
4. Cribier A, Eltchaninoff H, Tron C, Bauer F, Agatiello C, Sebagh L, et al. Early experience with percutaneous transcatheter implantation of heart valve prosthesis for the treatment of end stage inoperable patients with calcifc aortic stenosis. J Am Coll Cardiol 2004; 43: 698-703.
5. Grube E, Laborde JC, Gerckens U, Felderhoff T, Sauren B, Buellesfeld L, et al. Percutaneous implantation of the CoreValve self-expanding valve prosthesis in high-risk patients with aortic valve disease: The Siegburg frst-in-man study. Circulation 2006; 114: 1616-1624.
6. Heistad DD, Wakisaka Y, Miller J, Chu Y, Pena-Silva R. Novel aspects of oxidative stress in cardiovascular diseases. Circ J 2009; 73: 201-207.
7. Linhartová K, Veselka J, Sterbáková G, Racek J, Topolcan O, Cerbák R. Parathyroid hormone and vitamin D levels are independently associated with calcifc aortic stenosis. Circ J 2008; 72: 245-250.
8. Ross J Jr, Braunwald E. Aortic stenosis. Circulation 1968; 38(Suppl): 61-67.
9. Roberts WC, Ko JM, Filardo G. Comparison of heavier versus lighter operatively excised stenotic aortic valves in adults with aortic stenosis and implications for percutaneous aortic valve implantation without replacement. Am J Cardiol 2009; 104: 393-405.
10. Webb JG, Chandavimol M, Thompson CR, Ricci DR, Carere RG, Munt BI, et al. Percutaneous aortic valve implantation retrograde from the femoral artery. Circulation 2006; 113: 842-850.
11. Thomas M, Schymik G, Walther T, Himbert D, Lefèvre T, Treede H, et al. Thirty-day results of the SAPIEN aortic bioprosthesis european outcome (SOURCE) Registry: A European registry of trans-catheter aortic valve implantation using the Edwards SAPIEN valve. Circulation 2010; 122: 62-69.
12. Piazza N, Grube E, Gerckens U, den Heijer P, Linke A, Luha O, et al. Procedural and 30-day outcomes following transcatheter aortic valve implantation using the third generation (18Fr) Core Valve ReValving system: Results from the multicentre, expanded evaluation registry 1-year following CE mark approval. EuroIntervention 2008; 4: 242-249.
13. Piazza N, Onuma Y, Jesserun E, Kint PP, Maugenest AM, Anderson RH, et al. Early and persistent intraventricular conduction abnormalities and requirements for pacemaking after percutaneous replacement of the aortic valve. JACC Cardiovasc Interv 2008; 1: 310-316.
14. Fraccaro C, Napodano M, Tarantini G, Gasparetto V, Gerosa G, R, Bonato R, et al. Expanding the eligibility for transcatheter aortic valve implantation the trans-subclavian retrograde approach using: The III generation Core Valve ReValving system. JACC Cardiovasc Interv 2009; 2: 828-833.
15. Olsen LK, Engstrøm T, Søndergaard L. Transcatheter valve-in-valve implantation due to severe aortic regurgitation in a degenerated aortic homograft. J Invasive Cardiol 2009; 21: E197-E200.